Skip to content

Apotheek Beekstraat: what changed

What changed

Apotheek Beekstraat

BE 0473.306.748
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€77,599
2024 · €113,949-€36,350
Equity
€459,600
2024 · €415,411+€44,189
Cash
€135,320
2024 · €250,744-€115,424
Balance sheet total
€752,161
2024 · €1.2m-€423,979

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€339,351

    down €339,351 (-89.5%), from €379,146 to €39,795

    of which Land and buildings: -€331,928

  • Cash -€115,424

    down €115,424 (-46.0%), from €250,744 to €135,320

    mainly Other debts (-€421,438) and Receivables within one year (-€57,808)

  • Receivables within one year +€57,808

    up €57,808 (+28.8%), from €200,709 to €258,517

    of which Trade receivables: +€34,232

  • Stocks and contracts -€29,797

    down €29,797 (-8.8%), from €336,999 to €307,202

Equity and liabilities
  • Other debts -€421,438

    down €421,438 (-72.1%), from €584,477 to €163,039

  • Contributions +€285,072

    up €285,072 (+1,533%), from €18,600 to €303,672

  • Reserves -€240,882

    down €240,882 (-60.7%), from €396,811 to €155,929

    of which Distributable reserves: -€200,427

  • Trade debts -€44,118

    down €44,118 (-32.2%), from €137,025 to €92,907

  • Accrued charges and deferred income -€14,339

    down €14,339 (-94.3%), from €15,212 to €873

Income statement
  • Gross operating margin -€61,851

    down €61,851 (-13.1%), from €473,925 to €412,074

  • Depreciation -€37,799

    down €37,799 (-76.5%), from €49,418 to €11,619

  • Staff costs +€26,817

    up €26,817 (+11.3%), from €237,213 to €264,029

  • Financial charges -€11,000

    down €11,000 (-35.3%), from €31,183 to €20,183

  • Taxes -€10,186

    down €10,186 (-25.9%), from €39,257 to €29,071

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €113,949
Gross operating margin -€61,851
Staff costs -€26,817
Depreciation +€37,799
Other operating charges -€5,329
Other operating items -€190
Financial income -€1,148
Financial charges +€11,000
Other financial items -€1
Taxes +€10,186
Deferred taxes and other +€1
Result 2025 €77,599
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€409,746
Investment +€327,732
Financing -€33,409
Cash 2024 €250,744
Net result for the year +€77,599
Depreciation +€11,619
Stocks and contracts +€29,797
Receivables within one year -€57,808
Deferred charges and accrued income -€2,785
Trade debts -€44,118
Tax, wage and social debts +€3,038
Advances received +€8,689
Other debts -€421,438
Accrued charges and deferred income -€14,339
Investment in fixed assets (net) +€327,732
Contributions, distributions and other -€33,409
Not broken down -€1
Cash 2025 €135,320
brings cash intakes cash outdifference in the filed balance sheets themselves
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,176,140 €752,161 -€423,979 -36.0%
Fixed assets 21/28 €379,177 €39,826 -€339,351 -89.5%
Tangible fixed assets 22/27 €379,146 €39,795 -€339,351 -89.5%
Land and buildings 22 €348,923 €16,995 -€331,928 -95.1%
Plant, machinery and equipment 23 €21,290 €16,563 -€4,727 -22.2%
Furniture and vehicles 24 €8,933 €6,237 -€2,696 -30.2%
Financial fixed assets 28 €31 €31 +€0 0.0%
Current assets 29/58 €796,963 €712,336 -€84,627 -10.6%
Stocks and contracts in progress 3 €336,999 €307,202 -€29,797 -8.8%
Stocks 30/36 €336,999 €307,202 -€29,797 -8.8%
Amounts receivable within one year 40/41 €200,709 €258,517 +€57,808 +28.8%
Trade receivables 40 €156,650 €190,882 +€34,232 +21.9%
Other amounts receivable 41 €44,058 €67,635 +€23,577 +53.5%
Cash at bank and in hand 54/58 €250,744 €135,320 -€115,424 -46.0%
Deferred charges and accrued income 490/1 €8,511 €11,296 +€2,785 +32.7%
Total equity and liabilities 10/49 €1,176,140 €752,161 -€423,979 -36.0%
Equity 10/15 €415,411 €459,600 +€44,189 +10.6%
Contributions 10/11 €18,600 €303,672 +€285,072 +1,533%
Reserves 13 €396,811 €155,929 -€240,882 -60.7%
Tax-exempt reserves 132 €50,405 €9,950 -€40,455 -80.3%
Distributable reserves 133 €346,406 €145,979 -€200,427 -57.9%
Profit (loss) carried forward 14 €0 - =
Amounts payable 17/49 €760,729 €292,561 -€468,168 -61.5%
Amounts payable after more than one year 17 €0 - =
Financial debts 170/4 €0 - =
Amounts payable within one year 42/48 €745,517 €291,688 -€453,829 -60.9%
Trade debts 44 €137,025 €92,907 -€44,118 -32.2%
Suppliers 440/4 €137,025 €92,907 -€44,118 -32.2%
Advances received on contracts in progress 46 - €8,689 +€8,689
Taxes, remuneration and social security 45 €24,015 €27,053 +€3,038 +12.6%
Taxes 450/3 €309 €3,228 +€2,919 +944%
Remuneration and social security 454/9 €23,706 €23,825 +€119 +0.5%
Other amounts payable 47/48 €584,477 €163,039 -€421,438 -72.1%
Accrued charges and deferred income 492/3 €15,212 €873 -€14,339 -94.3%
Non-recurring operating income 76A €0 - =
Remuneration, social security and pensions 62 €237,213 €264,029 +€26,817 +11.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €49,418 €11,619 -€37,799 -76.5%
Other operating charges 640/8 €6,424 €11,753 +€5,329 +83.0%
Non-recurring operating charges 66A - €190 +€190
Gross operating margin 9900 €473,925 €412,074 -€61,851 -13.1%
Operating profit (loss) 9901 €180,870 €124,483 -€56,387 -31.2%
Financial income 75/76B €3,518 €2,370 -€1,148 -32.6%
Recurring financial income 75 €3,518 €2,370 -€1,148 -32.6%
Financial charges 65/66B €31,183 €20,183 -€11,000 -35.3%
Recurring financial charges 65 €31,183 €20,183 -€11,000 -35.3%
Profit (loss) for the period before taxes 9903 €153,205 €106,669 -€46,536 -30.4%
Income taxes 67/77 €39,257 €29,071 -€10,186 -25.9%
Profit (loss) for the period 9904 €113,949 €77,599 -€36,350 -31.9%
Profit (loss) for the period to be appropriated 9905 €113,949 €77,599 -€36,350 -31.9%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.